tradingkey.logo
tradingkey.logo
Search

Climb Bio Inc

CLYM
Add to Watchlist
12.100USD
+0.200+1.68%
Close 07-31 16:00ETQuotes delayed by 15 min
825.03MMarket Cap
LossP/E TTM

CLYM Financials

See Climb Bio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Climb Bio Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.20/-0.27
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.88
42.48%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
34.69%-0.20
-105.62%-0.26
-42.79%-0.19
92.91%-0.13
-401.69%-0.31
5.52%-0.12
9.45%-0.13
-829.95%-1.81
92.70%-0.06
55.07%-0.13
---0.15
---0.19
---0.84
---0.29
----
----
----
----
----
----
Net Profit
33.97%-13.72M
-108.13%-17.52M
-44.89%-12.89M
84.21%-8.67M
-1124.57%-20.78M
-131.15%-8.42M
-124.17%-8.89M
-951.51%-54.89M
92.39%-1.70M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
26.39%-7.76M
11.47%-9.68M
-34.40%-14.60M
32.93%-13.20M
33.24%-10.54M
-302.24%-10.94M
-421.36%-10.86M
Operating profit
33.92%-15.21M
-155.47%-19.30M
-26.93%-14.89M
-126.54%-10.68M
-665.99%-23.02M
-147.23%-7.55M
-145.49%-11.73M
21.20%-4.71M
60.72%-3.00M
68.02%-3.06M
45.37%-4.78M
56.35%-5.98M
41.74%-7.65M
10.74%-9.55M
6.77%-8.75M
-57.36%-13.70M
-90.90%-13.13M
-79.91%-10.70M
-315.36%-9.38M
-441.48%-8.71M
Net Profit
33.97%-13.72M
-108.13%-17.52M
-44.89%-12.89M
84.21%-8.67M
-1124.57%-20.78M
-131.15%-8.42M
-124.17%-8.89M
-951.51%-54.89M
92.39%-1.70M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
26.39%-7.76M
11.47%-9.68M
-34.40%-14.60M
32.93%-13.20M
33.24%-10.54M
-302.24%-10.94M
-421.36%-10.86M
Current assets
13.09%113.40M
-31.65%105.85M
-53.97%90.96M
-61.33%87.38M
-8.19%100.28M
40.47%154.87M
75.76%197.61M
97.82%226.00M
-9.11%109.22M
-17.96%110.25M
-15.57%112.43M
-14.15%114.24M
-9.84%120.17M
-9.35%134.39M
-16.05%133.17M
26.98%133.08M
153.69%133.28M
--148.25M
--158.63M
--104.80M
Total current liabilities
-42.14%4.07M
41.63%6.98M
44.58%4.95M
65.86%6.21M
138.51%7.04M
74.06%4.93M
17.99%3.42M
3.40%3.74M
-39.98%2.95M
-53.53%2.83M
-53.81%2.90M
-52.48%3.62M
-28.73%4.92M
0.98%6.10M
12.34%6.28M
33.27%7.61M
69.43%6.90M
--6.04M
--5.59M
--5.71M
Total assets
-24.09%152.37M
-22.77%167.74M
-17.95%182.30M
-14.88%192.39M
83.60%200.74M
96.60%217.19M
97.10%222.20M
94.38%226.02M
-10.44%109.33M
-18.17%110.47M
-19.97%112.73M
-22.54%116.27M
-24.83%122.08M
-22.08%134.99M
-22.71%140.86M
39.47%150.10M
202.54%162.42M
--173.24M
--182.25M
--107.63M
Total liabilities
-41.71%4.29M
37.00%7.27M
54.86%5.30M
77.01%6.62M
149.32%7.36M
84.88%5.31M
14.37%3.42M
-0.85%3.74M
-43.54%2.95M
-54.28%2.87M
-53.95%2.99M
-52.06%3.77M
-28.20%5.22M
3.96%6.28M
16.26%6.50M
37.76%7.87M
78.80%7.28M
--6.04M
--5.59M
--5.71M
Total equity
-23.42%148.09M
-24.26%160.47M
-19.09%177.00M
-16.43%185.76M
81.78%193.38M
96.92%211.88M
99.35%218.78M
97.58%222.28M
-8.96%106.38M
-16.41%107.60M
-18.32%109.74M
-20.90%112.50M
-24.68%116.86M
-23.02%128.72M
-23.95%134.36M
39.56%142.24M
212.69%155.14M
--167.20M
--176.66M
--101.91M
Net operating income
6.84%-14.38M
-183.19%-15.63M
-60.68%-12.14M
-1571.36%-11.15M
-748.49%-15.43M
-483.00%-5.52M
-316.48%-7.55M
91.63%-667.00K
88.01%-1.82M
88.79%-947.00K
183.59%3.49M
42.97%-7.96M
-40.80%-15.18M
-7.17%-8.45M
67.80%-4.17M
-64.67%-13.97M
-59.93%-10.78M
-40.18%-7.88M
-444.60%-12.97M
-125.08%-8.48M
Net investment
69.70%-12.96M
147.82%25.54M
121.26%15.26M
149.62%4.79M
-410.89%-42.75M
-245.34%-53.41M
-356.05%-71.79M
-502.44%-9.64M
137.21%13.75M
157.37%36.75M
229.50%28.04M
-110.21%-1.60M
243.67%5.80M
277.34%14.28M
107.96%8.51M
--15.69M
---4.04M
-199.67%-8.05M
---106.92M
----
Net financing
--5.00K
-151.22%-21.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-85.76%41.00K
330.11%2.27M
534908.33%128.40M
1400.00%15.00K
--288.00K
--528.00K
--24.00K
--1.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-99.23%38.00K
--83.14M
--59.97M

FAQs

What are the current assets of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its current assets were 105.85M, with a year-on-year change of -31.65.

What are the total assets of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its total assets of Climb Bio Inc were 167.74M, with a year-on-year change of -22.77.

What are the total liabilities of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its total liabilities of Climb Bio Inc were 7.27M, with a year-on-year change of 37.00.

What is the total equity of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its total equity of Climb Bio Inc was 160.47M, with a year-on-year change of -24.26.

What is the net operating income of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its net operating income of Climb Bio Inc was -67.88M, with a year-on-year change of -151.39.

What is the net investment of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its net investment of Climb Bio Inc was 2.83M, with a year-on-year change of 102.34.

What is the net financing of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its net financing of Climb Bio Inc was -21.00K, with a year-on-year change of -100.02.

What is the Earnings Per Share (EPS) of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.88, with a year-on-year change of 42.48.

What is the net income of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its net income was -59.85M, with a year-on-year change of 19.01.

What is the Return on Equity (ROE) of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its Return on Equity (ROE) was -32.15, with a year-on-year change of 30.51.

What is the Return on Assets (ROA) of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its Return on Assets (ROA) was -31.10, with a year-on-year change of 31.06.

What is the operating profit of Climb Bio Inc?

According to Climb Bio Inc's FY2025 earnings report, its operating profit was -67.88M, with a year-on-year change of -151.39.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.